(Q70727374)
Statements
Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation (English)
W W Hancock
M H Sayegh
C A Kwok
H L Weiner
scientific article published on 01 May 1993
No description defined